Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:ACET) with a Outperform and maintains $30 price target.
$1000 Invested In Texas Instruments 15 Years Ago Would Be Worth This Much Today
Texas Instruments (NASDAQ:TXN) has outperformed the market over the past 15 years by 4.3% on an annualized basis producing an average annual return of 10.64%. Currently, Texas Instruments has a market capitalization of $151.23 billion.
